Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Coronavirus Report – Part 67: Pandemic Causes 75% Drop in Clinical Trials for Early April

Filed Under: Coronavirus, Pharma Tagged With: , , , ,

The global COVID-19 pandemic has stopped many clinical trials for new drugs in their tracks. Research from Medidata Solutions Inc.,…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Coronavirus Report – Part 27: Pandemic Sees Clinical Trials for New Drugs Suspended, Postponed
Coronavirus Report – Part 27: Pandemic Sees Clinical Trials…
Coronavirus Report – Part 58: Clinical Trials Begin for Slew of Potential Vaccines
Coronavirus Report – Part 58: Clinical Trials Begin for Slew…
LSII to Launch Clinical Trials of Muse Cells to Treat Respiratory Failure in COVID-19 Patients
LSII to Launch Clinical Trials of Muse Cells to Treat…
Just How Effective Will Vaccines Be in Combating the COVID-19 Pandemic?
Just How Effective Will Vaccines Be in Combating the…
Coronavirus Report – Part 77: Japan’s Pharmaceutical Companies Move in Quick Order to Treat Infection
Coronavirus Report – Part 77: Japan’s Pharmaceutical…
Coronavirus Report – Part 91: GSK Japan President Paul Lirette Discusses Strategy and Moves in Pandemic Times
Coronavirus Report – Part 91: GSK Japan President Paul…